|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.515 CHF | +6.44% |
|
+19.17% | +43.11% |
| 06-12 | Federal Council Clears Path for Pension Increases and Pharmacy Reform | DP |
| 06-03 | Pharmacy fee hike to be implemented in two stages | DP |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 412.9 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 42.8% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 614.7 | 653.6 | 668.9 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 44.05% | 6.33% | 2.33% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -5.02x | -9.02x | -23.1x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.24x | 1.25x | 1.47x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.2x | 0.4x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.34x | 0.3x | 0.28x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.5x | 0.48x | 0.46x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -34.6x | 45.2x | 15.7x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -9.21x | -18.5x | -67.4x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -8.6x | -18.9x | -36.4x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -11.6% | -5.28% | -2.75% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.593 | -0.8866 | -0.3464 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,218 | 1,369 | 1,463 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -17.79 | 14.46 | 42.56 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -66.73 | -35.38 | -9.926 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -84.15 | -48.29 | -23.38 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 201.8 | 240.7 | 255.9 |
| Reference price 2 | 235.500 | 25.560 | 73.750 | 19.980 | 5.950 | 8.000 | 8.000 | 8.000 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 48,496 | - | - |
| Announcement Date | 3/24/22 | 3/24/23 | 3/20/24 | 3/12/25 | 3/18/26 | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.02x | 0.48x | -33.15x | -.--% | 489M | |
| 17.4x | 0.7x | 11.12x | -.--% | 14.93B | |
| 21.18x | 1.05x | 16.21x | -.--% | 7.08B | |
| 16.37x | 0.71x | 7.41x | 2.08% | 5.72B | |
| 12.74x | 0.81x | 5.83x | 3.37% | 3.62B | |
| 16.11x | 0.98x | 7.32x | 4.01% | 3.38B | |
| 15.07x | 1.27x | 7.73x | 5.49% | 3.37B | |
| 12.73x | 0.51x | 4.09x | 5.32% | 2.79B | |
| 41.39x | - | - | - | 2.69B | |
| Average | 16.44x | 0.82x | 3.32x | 2.53% | 4.9B | |
| Weighted average by Cap. | 18.13x | 0.83x | 9.43x | 1.71% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
